Clinical Trial Update: Comparisons of Intravenous Ceftriaxone With Intravenous Moxifloxacin in ERCP [Phase 2]

View source ↗

Summary

A Phase 2 trial comparing intravenous ceftriaxone with intravenous moxifloxacin for cholangitis during ERCP has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cholangitis

Drugs mentioned

• Moxifloxacin (moxifloxacin)
• ceftriaxone (ceftriaxone sodium)

Snippet

Sponsor: Kangbuk Samsung Hospital | Conditions: Cholangitis | Phase 2 | Status: COMPLETED